← Evidence map

ArticleNature2021

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.

Ivana Yen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

82 papers cite itlatest 60 shown

2021
…
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33953400